I

Imperial Ginseng Products Ltd
XTSX:IGP

Watchlist Manager
Imperial Ginseng Products Ltd
XTSX:IGP
Watchlist
Price: 0.1 CAD Market Closed
Market Cap: CA$765k

Balance Sheet

Balance Sheet Decomposition
Imperial Ginseng Products Ltd

Balance Sheet
Imperial Ginseng Products Ltd

Rotate your device to view
Balance Sheet
Currency: CAD
Jun-2002 Jun-2003 Jun-2004 Jun-2005 Jun-2006 Jun-2007 Jun-2008 Jun-2009 Jun-2010 Jun-2011 Jun-2012 Jun-2013 Jun-2014 Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023 Jun-2024 Jun-2025
Assets
Cash & Cash Equivalents
0
0
0
1
2
0
0
0
1
3
1
1
6
6
6
10
6
5
2
4
11
17
0
0
Cash Equivalents
0
0
0
1
2
0
0
0
1
3
1
1
6
6
6
10
6
5
2
4
11
17
0
0
Total Receivables
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
Accounts Receivables
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
Inventory
1
0
1
0
0
0
0
0
0
0
0
0
0
7
3
0
0
2
2
1
1
0
0
0
Other Current Assets
3
3
5
4
3
3
3
3
3
2
3
5
3
1
6
5
13
9
3
2
1
0
0
0
Total Current Assets
4
3
6
6
4
3
3
4
4
5
5
6
9
14
14
15
20
17
7
7
13
17
0
0
PP&E Net
2
2
1
1
1
1
1
1
1
1
8
8
10
10
12
16
18
15
12
5
3
0
0
0
PP&E Gross
2
2
1
1
1
1
1
1
1
1
8
0
0
0
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
3
4
3
3
3
3
4
4
4
4
2
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
4
4
3
3
4
5
5
4
4
4
0
0
0
0
0
0
0
0
1
1
0
1
0
0
Total Assets
10
N/A
9
-8%
11
+19%
9
-14%
10
+5%
9
-6%
9
+4%
9
-8%
9
-2%
10
+14%
13
+31%
15
+15%
19
+31%
24
+28%
27
+9%
32
+19%
39
+23%
32
-18%
21
-35%
13
-37%
16
+26%
18
+13%
0
-98%
0
-40%
Liabilities
Accounts Payable
1
2
1
0
1
1
1
0
0
1
1
1
1
1
1
1
2
2
1
1
1
1
0
0
Short-Term Debt
1
0
0
0
1
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
1
0
0
0
0
0
0
0
2
3
3
0
0
0
0
1
1
2
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
1
0
0
0
Total Current Liabilities
3
3
1
1
2
1
1
1
0
3
3
3
2
2
2
3
3
3
2
1
1
1
0
0
Long-Term Debt
1
0
0
0
0
1
1
1
2
0
1
1
3
2
2
2
2
2
1
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
3
5
3
1
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
Total Liabilities
4
N/A
4
-14%
1
-78%
1
-33%
2
+254%
2
-19%
2
+45%
2
+3%
2
-17%
3
+39%
4
+56%
5
+6%
4
-6%
6
+40%
7
+14%
8
+16%
10
+32%
8
-22%
4
-46%
1
-78%
2
+113%
1
-43%
0
-97%
0
+86%
Equity
Common Stock
42
42
52
52
52
52
52
52
52
52
52
52
53
35
35
35
35
35
35
35
35
35
18
18
Retained Earnings
45
47
43
44
45
46
46
47
47
46
44
43
39
17
16
12
7
12
20
24
22
19
19
19
Additional Paid In Capital
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Other Equity
8
10
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
5
N/A
5
-3%
10
+88%
9
-13%
8
-11%
7
-3%
7
-5%
6
-12%
7
+4%
7
+6%
8
+21%
10
+19%
15
+48%
18
+25%
20
+7%
24
+21%
29
+20%
24
-16%
16
-32%
12
-27%
14
+19%
17
+21%
0
-98%
0
-53%
Total Liabilities & Equity
10
N/A
9
-8%
11
+19%
9
-14%
10
+5%
9
-6%
9
+4%
9
-8%
9
-2%
10
+14%
13
+31%
15
+15%
19
+31%
24
+28%
27
+9%
32
+19%
39
+23%
32
-18%
21
-35%
13
-37%
16
+26%
18
+13%
0
-98%
0
-40%
Shares Outstanding
Common Shares Outstanding
1
1
1
2
2
2
2
2
2
2
2
2
7
7
7
7
7
7
7
7
7
8
8
8
Preferred Shares Outstanding
22
22
0
0
1
1
1
1
1
1
1
0
1
0
0
0
0
0
0
0
0
0
0
0